PRICE T ROWE ASSOCIATES INC /MD/ - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 56 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$47,401
+6.6%
3,000,037
+2.1%
0.01%
+16.7%
Q2 2023$44,487
+2.8%
2,938,308
-1.5%
0.01%0.0%
Q1 2023$43,267
+6.2%
2,983,863
-1.0%
0.01%
-14.3%
Q4 2022$40,754
-99.9%
3,014,377
+1.4%
0.01%
-12.5%
Q3 2022$46,840,000
+57.8%
2,972,050
+21.9%
0.01%
+100.0%
Q2 2022$29,689,000
+26.7%
2,437,498
-2.3%
0.00%
+100.0%
Q1 2022$23,425,000
-32.3%
2,494,714
+23.5%
0.00%
-33.3%
Q4 2021$34,593,0002,020,6370.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$7,706,60860.04%
MPM ASSET MANAGEMENT LLC 4,425,784$67,006,37032.86%
5AM Venture Management, LLC 4,408,379$66,742,85816.63%
StepStone Group LP 761,277$11,525,7342.13%
TCG Crossover Management, LLC 584,955$8,856,2191.45%
Redmile Group, LLC 1,311,572$19,857,2000.76%
Nan Fung Group Holdings Ltd 49,082$743,1010.48%
Baker Brothers Advisors 4,865,819$73,668,5000.43%
Corton Capital Inc. 18,067$273,5340.13%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,589,7000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders